Skip to content

Researchers are taking aim at the counterfeit drug and medical supplies market

People in this story

The skyrocketing demand for COVID-19 treatment has scientists working overtime to produce medicines and vaccines. But simply creating these therapies isn’t the only hurdle facing researchers and world leaders. 

Once a vaccine is developed, for example, it will inevitably be in short supply. And if rich countries continue to monopolize doses, poorer countries will be left to fend for themselves.  

Situations like this fuel the counterfeit drug market, says Nikos Passas, professor of criminology and criminal justice at Northeastern. When people are desperate, they’ll take whatever treatments they can get. And that can be incredibly dangerous to people’s health.

Continue reading at News@Northeastern.

More Stories

Professor Brandon Welsh Publishes Book On The Globalization of Evidence-Based Policing


Voters rejected the latest police reform measure in Minneapolis. Here’s why.


A New Guide Helps Schools Deal With Hate Crimes

Faculty Stories